company background image
CBAV logo

Clínica Baviera BME:CBAV Stock Report

Last Price

€29.00

Market Cap

€472.8m

7D

1.8%

1Y

54.3%

Updated

18 Mar, 2024

Data

Company Financials

CBAV Stock Overview

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics.

CBAV fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends4/6

Clínica Baviera, S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Clínica Baviera
Historical stock prices
Current Share Price€29.00
52 Week High€29.30
52 Week Low€17.30
Beta0.62
1 Month Change20.33%
3 Month Change26.09%
1 Year Change54.26%
3 Year Change113.24%
5 Year Change127.45%
Change since IPO27.98%

Recent News & Updates

Clínica Baviera (BME:CBAV) Might Become A Compounding Machine

Mar 01
Clínica Baviera (BME:CBAV) Might Become A Compounding Machine

Recent updates

Clínica Baviera (BME:CBAV) Might Become A Compounding Machine

Mar 01
Clínica Baviera (BME:CBAV) Might Become A Compounding Machine

Clínica Baviera's (BME:CBAV) Dividend Will Be €0.405

Nov 20
Clínica Baviera's (BME:CBAV) Dividend Will Be €0.405

Investors Shouldn't Overlook Clínica Baviera's (BME:CBAV) Impressive Returns On Capital

Jan 20
Investors Shouldn't Overlook Clínica Baviera's (BME:CBAV) Impressive Returns On Capital

These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely

Sep 15
These 4 Measures Indicate That Clínica Baviera (BME:CBAV) Is Using Debt Safely

Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)

Apr 12
Investors Shouldn't Overlook The Favourable Returns On Capital At Clínica Baviera (BME:CBAV)

Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly

Mar 21
Clínica Baviera (BME:CBAV) Seems To Use Debt Rather Sparingly

Clínica Baviera, S.A.'s (BME:CBAV) Stock Is Going Strong: Is the Market Following Fundamentals?

Feb 22
Clínica Baviera, S.A.'s (BME:CBAV) Stock Is Going Strong: Is the Market Following Fundamentals?

Shareholders Of Clínica Baviera (BME:CBAV) Must Be Happy With Their 177% Total Return

Jan 30
Shareholders Of Clínica Baviera (BME:CBAV) Must Be Happy With Their 177% Total Return

Here's What To Make Of Clínica Baviera's (BME:CBAV) Returns On Capital

Jan 09
Here's What To Make Of Clínica Baviera's (BME:CBAV) Returns On Capital

Here's Why We Think Clínica Baviera's (BME:CBAV) Statutory Earnings Might Be Conservative

Dec 19
Here's Why We Think Clínica Baviera's (BME:CBAV) Statutory Earnings Might Be Conservative

Clínica Baviera (BME:CBAV) Has A Pretty Healthy Balance Sheet

Nov 28
Clínica Baviera (BME:CBAV) Has A Pretty Healthy Balance Sheet

Shareholder Returns

CBAVES HealthcareES Market
7D1.8%-3.3%2.8%
1Y54.3%0.07%16.7%

Return vs Industry: CBAV exceeded the Spanish Healthcare industry which returned 0.1% over the past year.

Return vs Market: CBAV exceeded the Spanish Market which returned 16.7% over the past year.

Price Volatility

Is CBAV's price volatile compared to industry and market?
CBAV volatility
CBAV Average Weekly Movement3.5%
Healthcare Industry Average Movement4.5%
Market Average Movement3.2%
10% most volatile stocks in ES Market6.7%
10% least volatile stocks in ES Market0.7%

Stable Share Price: CBAV has not had significant price volatility in the past 3 months.

Volatility Over Time: CBAV's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a1,466Eduardo Baviera Sabaterhttps://www.clinicabaviera.com

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments.

Clínica Baviera, S.A. Fundamentals Summary

How do Clínica Baviera's earnings and revenue compare to its market cap?
CBAV fundamental statistics
Market cap€472.79m
Earnings (TTM)€36.73m
Revenue (TTM)€224.92m

12.9x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CBAV income statement (TTM)
Revenue€224.92m
Cost of Revenue€157.91m
Gross Profit€67.02m
Other Expenses€30.28m
Earnings€36.73m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)2.25
Gross Margin29.80%
Net Profit Margin16.33%
Debt/Equity Ratio2.7%

How did CBAV perform over the long term?

See historical performance and comparison

Dividends

4.5%

Current Dividend Yield

41%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.